Sectors
AURA
Aura Biosciences, Inc.
7.11
4 x 5.18
6 x 9.22
bid
ask
-
0.29
3.99%
02:09 PM
timesize
| Ytd | 30.37% | |
| 1y | 13.50% |
7.06
day range
7.40
4.73
52 week range
9.54
| Open | 7.39 | Prev Close | 7.40 | Low | 7.06 | High | 7.40 | Mkt Cap | 736.30M |
| Vol | 292.86K | Avg Vol | 651.62K | EPS | -1.73 | P/E | N/A | Forward P/E | -4.05 |
| Beta | 0.40 | Short Ratio | 4.79 | Inst. Own | 77.55% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 7.28 | 200-d Avg | 6.55 | 1yr Est | 21.83 |
| Income Statement | |||
| Operating Expenses | 48.07M | ||
| Research and Development Expense | 30.75M | ||
| Selling, General and Administrative Expense | 17.32M | ||
| Operating Income | -48.07M | ||
| Income Tax Expense | 29.00K | ||
| Net Income | -45.64M | ||
| Net Income Common Stock | -45.64M | ||
| Net Income Common Stock (USD) | -45.64M | ||
| Consolidated Income | -45.64M | ||
| Earnings per Basic Share | -0.48 | ||
| Earnings per Basic Share (USD) | -0.48 | ||
| Earnings per Diluted Share | -0.48 | ||
| Earning Before Interest & Taxes (EBIT) | -45.61M | ||
| Earning Before Interest & Taxes (USD) | -45.61M | ||
| Weighted Average Shares | 94.86M | ||
| Weighted Average Shares Diluted | 94.86M | ||
| Balance Sheet | |||
| Cash and Equivalents | 68.60M | ||
| Cash and Equivalents (USD) | 68.60M | ||
| Investments | 256.00M | ||
| Investments Current | 256.00M | ||
| Current Assets | 329.03M | ||
| Property, Plant & Equipment Net | 17.19M | ||
| Total Assets | 348.13M | ||
| Debt Current | 3.29M | ||
| Total Debt | 16.59M | ||
| Current Liabilities | 19.56M | ||
| Debt Non-Current | 13.30M | ||
| Total Liabilities | 32.86M | ||
| Accumulated Retained Earnings (Deficit) | -559.74M | ||
| Accumulated Other Comprehensive Income | -670.00K | ||
| Shareholders Equity | 315.27M | ||
| Shareholders Equity (USD) | 315.27M | ||
| Assets Non-Current | 19.10M | ||
| Total Debt (USD) | 16.59M | ||
| Liabilities Non-Current | 13.30M | ||
| Trade and Non-Trade Payables | 2.25M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 683.00K | ||
| Net Cash Flow from Financing | 241.75M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -16.78M | ||
| Capital Expenditure | -21.00K | ||
| Issuance (Purchase) of Equity Shares | 241.75M | ||
| Net Cash Flow from Investing | -226.03M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -226.01M | ||
| Net Cash Flow from Operations | -32.50M | ||
| Effect of Exchange Rate Changes on Cash | -173.00K | ||
| Share Based Compensation | 12.37M | ||